Discover 1,760 paid clinical trials in Ann Arbor, Michigan. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,760
Project 4: ACHIEVE PATHFINDER
for
Heart Failure
Location: Detroit MI
Sponsor: Henry Ford Health System
Sex: All
Age: 18+
Code: NCT06070428
Recruiting
Pre-Emptive LAVA-ECMO for Complex High-Risk TAVR
for
Severe Aortic Stenosis, Cardiogenic Shock,
Location: Detroit MI, Morristown NJ
Sponsor: Atlantic Health System
Sex: All
Age: 18 - 70+
Code: NCT07309029
Recruiting
A Study to Evaluate the Safety and Efficacy of NEXAGON® (Lufepirsen Ophthalmic Gel) in Subjects With PCED
for
Persistent Corneal Epithelial Defect
Location: Fraser MI, Carmel IN, Milwaukee WI, Madison WI,
Sponsor: Glaukos Corporation
Sex: All
Age: 2+
Code: NCT05966493
Phase 2, Recruiting
New
A Study to Test How Well BAY 3670549 Works and How Safe it is in Patients With Atrial Fibrillation
for
Atrial Fibrillation
Location: Detroit MI
Sponsor: Bayer
Sex: All
Age: 18 - 70+
Code: NCT07625215
Phase 2, Recruiting
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
for
Chronic Graft-Versus-Host Disease (cGVHD)
Location: Detroit MI, Cleveland OH, Columbus OH, Chicago IL,
Sponsor: Deciphera Pharmaceuticals, LLC
Sex: All
Age: 18+
Code: NCT06619561
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors
for
Cancer, Melanoma Stage III, Melanoma Stage IV,
Location: Detroit MI, Cleveland OH, Canton OH, Indianapolis IN,
Sponsor: Krystal Biotech, Inc.
Sex: All
Age: 18+
Code: NCT05970497
Phase 1, Phase 2, Recruiting
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
for
Hematologic Disorder, Bleeding Disorder,
Location: Detroit MI, Toledo OH, Cleveland OH, Akron OH,
Sponsor: American Thrombosis and Hemostasis Network
Sex: All
Age: 0+
Code: NCT04398628
Recruiting
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
for
Pancreatic Neuroendocrine Tumor (pNET),
Location: Detroit MI, Grand Rapids MI, Cleveland OH, London,
Sponsor: Exelixis
Sex: All
Age: 18+
Code: NCT06943755
Phase 2, Phase 3, Recruiting
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
for
Non-Small-Cell Lung Cancer,
Location: Detroit MI, Columbus OH, Chicago IL,
Sponsor: ArriVent BioPharma, Inc.
Sex: All
Age: 18+
Code: NCT07185997
Phase 3, Recruiting
Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/ Refractory Small Cell Lung Cancer
for
Small Cell Lung Cancer
Location: Detroit MI, Los Angeles CA
Sponsor: SciTech Development, Inc.
Sex: All
Age: 18+
Code: NCT06922539
Phase 1, Recruiting
A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)
for
Small-cell Lung Cancer
Location: Detroit MI, Cleveland OH, Mayfield Heights OH, Akron OH,
Sponsor: Zai Lab (Shanghai) Co., Ltd.
Sex: All
Age: 18+
Code: NCT07218146
Phase 3, Recruiting
Study of Sacituzumab Govitecan With Atezolizumab/Durvalumab as Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer
for
Small Cell Lung Cancer ( SCLC ),
Location: Detroit MI
Sponsor: Bindu R Potugari
Sex: All
Age: 18+
Code: NCT07339059
Phase 2, Recruiting
A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
for
Head and Neck Squamous Cell Carcinoma (HNSCC)
Location: Detroit MI, Columbus OH, Evanston IL, Edgewood KY,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06769698
Phase 2, Recruiting
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
for
Solid Tumor, Non-Small Cell Lung Cancer, Head and Neck Cancer,
Location: Detroit MI, Louisville KY, Atlanta GA, Omaha NE,
Sponsor: Inhibrx Biosciences, Inc
Sex: All
Age: 18+
Code: NCT04198766
Phase 1, Phase 2, Recruiting
A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
Location: Detroit MI, Columbus OH, Chicago IL, Toronto,
Sponsor: Nuvalent Inc.
Sex: All
Age: 12+
Code: NCT05118789
Phase 1, Phase 2, Recruiting
Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations
Location: Detroit MI, Toronto, Baltimore MD, New York NY,
Sponsor: Tyra Biosciences, Inc
Sex: All
Age: 18+
Code: NCT06915753
Phase 1, Recruiting
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)